| 2024 | | Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines | 손주혁, 장석준 |
| 2024 | | Improved prediction of clinical pregnancy using artificial intelligence with enhanced inner cell mass and trophectoderm images | 김미란 |
| 2024 | | Effect of high-dose polymeric nanoparticle micellar paclitaxel on improved progression-free survival in patients with optimally resected stage III or IV high-grade carcinoma of the ovary: a prospective cohort study with historical controls | 공태욱, 손주혁, 장석준 |
| 2024 | | Surgery for Recurrent Epithelial Ovarian Cancer | 장석준 |
| 2024 | | Ultrasonographic assessment of abnormal fetal growth related to uteroplacental-fetal biometrics and Doppler (U-AID) indices: Protocol for multicenter retrospective cohort study trial | 곽동욱 |
| 2024 | | Risk Factors of Postpartum Depression Among Korean Women: An Analysis Based on the Korean Pregnancy Outcome Study (KPOS) | 곽동욱 |
| 2024 | | Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer | 공태욱, 손주혁 |
| 2024 | | Risk Factors for Infertility in Korean Women | 황경주 |
| 2024 | | Extra-abdominal cytoreductive techniques in ovarian cancer: how far can (should) we go? | 장석준 |
| 2023 | | Spillage and displacement of indocyanine green-stained tissues from uterine cervix to pelvic peritoneum: A proof of concept study for colpotomy approach in minimally invasive surgery | 공태욱, 김지연, 손주혁, 장석준 |
| 2023 | | Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer | 공태욱, 김지연, 손주혁, 장석준 |
| 2023 | | Intranodal Lymphangiography and Embolization for the Treatment of Early Postoperative Lymphatic Leaks after Pelvic Surgery | 김진우, 원제환, 이경민, 장석준 |
| 2023 | | Optimum selection criteria for secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion group (GORILLA-3001) | 공태욱, 손주혁, 장석준 |
| 2023 | | Is minimally invasive radical surgery safe for patients with cervical cancer ≤2 cm in size? (MISAFE): Gynecologic Oncology Research Investigators coLLborAtion study (GORILLA-1003) | 공태욱, 김지연, 손주혁, 장석준 |
| 2023 | | Robot-assisted versus conventional laparoscopic surgery for endometrial cancer: long-term comparison of outcomes | 백지흠 |
| 2023 | | Cost-effectiveness of hyperthermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III-IV ovarian cancer from a randomized controlled phase III trial in Korea (KOV-HIPEC-01) | 장석준 |
| 2023 | | Impact of warm saline irrigation, hyperthermic intraperitoneal chemotherapy on postoperative pain in primary ovarian cancer from the KOV-HIPEC-01 randomized trial | 장석준 |
| 2023 | | Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3 | 공태욱 |
| 2023 | | Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1–2 with superficial myometrial invasion: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2001) | 공태욱, 김지연, 손주혁, 장석준 |
| 2023 | | Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004) | 공태욱, 김지연, 손주혁, 장석준 |
